NASDAQ:RMTI

Rockwell Medical Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy RMTI

*Your capital is at risk

$7.19

+0.0900 (+1.27%)

At Close: Jul 31, 2026

Rockwell Medical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 94.57. In total, the insiders bought 4.83M and sold 75.62K RMTI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	94.57
● Buy	4.83M shares
● Sell	75.62K shares
78% Buy Activity Moderate Negative Correlation
Buy Signal High Confidence Jul 01, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 94.57. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (78% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Oct 01, 2025 Sell	Common Stock S-Sale	Strobeck Mark President And CEO	CEO / President	6 926 Value: $8K
Oct 01, 2025 Sell	Common Stock S-Sale	Strobeck Mark President And CEO	CEO / President	6 926 Value: $8K
Oct 01, 2025 Sell	Common Stock S-Sale	Neri Jesse SVP And CFO	C-Suite Officer	886 Value: $1K
Oct 01, 2025 Sell	Common Stock S-Sale	Chole Timothy SVP And Cco	Officer	2 868 Value: $3K
Sep 23, 2025 Buy	Common Stock	Hunter Heather SVP, Chief Operating Officer	C-Suite Officer	0 Value: $0
Sep 23, 2025 Buy	Non-Qualified Stock Options	Hunter Heather SVP, Chief Operating Officer	C-Suite Officer	60 000 Value: $99.6K
Sep 23, 2025 Buy	Non-Qualified Stock Options	Hunter Heather SVP, Chief Operating Officer	C-Suite Officer	32 990 Value: $45.2K
Sep 23, 2025 Buy	Non-Qualified Stock Options	Hunter Heather SVP, Chief Operating Officer	C-Suite Officer	47 190 Value: $65.6K
Sep 23, 2025 Buy	Non-Qualified Stock Options	Hunter Heather SVP, Chief Operating Officer	C-Suite Officer	170 000 Value: $181.9K
Sep 23, 2025 Buy	Non-Qualified Stock Options	Hunter Heather SVP, Chief Operating Officer	C-Suite Officer	170 000 Value: $181.9K
Sep 23, 2025 Buy	Non-Qualified Stock Options	Hunter Heather SVP, Chief Operating Officer	C-Suite Officer	47 190 Value: $65.6K
Sep 23, 2025 Buy	Non-Qualified Stock Options	Hunter Heather SVP, Chief Operating Officer	C-Suite Officer	32 990 Value: $45.2K
Sep 23, 2025 Buy	Non-Qualified Stock Options	Hunter Heather SVP, Chief Operating Officer	C-Suite Officer	60 000 Value: $99.6K
Sep 23, 2025 Buy	Common Stock	Hunter Heather SVP, Chief Operating Officer	C-Suite Officer	0 Value: $0
Jul 01, 2025 Sell	Common Stock S-Sale	Chole Timothy SVP And Cco	Officer	2 868 Value: $2K
Jul 01, 2025 Sell	Common Stock S-Sale	Neri Jesse SVP And CFO	C-Suite Officer	886 Value: $727
Jul 01, 2025 Sell	Common Stock S-Sale	Strobeck Mark President And CEO	CEO / President	6 926 Value: $6K
Jul 01, 2025 Sell	Common Stock S-Sale	Strobeck Mark President And CEO	CEO / President	6 926 Value: $6K
Jul 01, 2025 Sell	Common Stock S-Sale	Neri Jesse SVP And CFO	C-Suite Officer	886 Value: $727
Jul 01, 2025 Sell	Common Stock S-Sale	Chole Timothy SVP And Cco	Officer	2 868 Value: $2K
May 20, 2025 Buy	Performance-based restricted stock units A-Award	Chole Timothy SVP, Chief Commercial Officer	Officer	85 000 Value: $909.5K
May 20, 2025 Buy	Performance-based restricted stock units A-Award	Timmins Megan C. EVP, Clo And Secretary	Officer	97 500 Value: $1.04M
May 20, 2025 Buy	Performance-based restricted stock units A-Award	Neri Jesse SVP, Finance And CFO	C-Suite Officer	97 500 Value: $1.04M
May 20, 2025 Buy	Performance-based restricted stock units A-Award	Strobeck Mark President And CEO	CEO / President	352 000 Value: $3.77M
May 20, 2025 Buy	Common Stock A-Award	Lau Joan Director	Director	50 000 Value: $535.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ROCKWELL MEDICAL

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stor...

Read Full Profile Here